Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8+ T lymphocyte activation

This publication has 27 references indexed in Scilit:

• A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major
  Vaccine, 2001
• Vervet Monkeys Vaccinated with KilledLeishmania majorParasites and Interleukin-12 Develop a Type 1 Immune Response but Are Not Protected against Challenge Infection
  Infection and Immunity, 2001
• Subunit Vaccination of Mice against New World Cutaneous Leishmaniasis: Comparison of Three Proteins Expressed in Amastigotes and Six Adjuvants
  Infection and Immunity, 2000
• Biochemical analysis and immunogenicity ofLeishmania majoramastigote fractions in cutaneous leishmaniasis
  Clinical and Experimental Immunology, 1997
• Parasite cysteine proteinases
  Perspectives in Drug Discovery and Design, 1996
• Clinical Spectrum of Leishmaniasis
  Clinical Infectious Diseases, 1996
• The Regulation of Immunity to Leishmania Major
  Annual Review of Immunology, 1995
• A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
  The Journal of Experimental Medicine, 1995
• Analysis of the Cellular Parameters of the Immune Responses contributing to Resistance and Susceptibility of Mice to Infection with the Intracellular Parasite, Leishmania major
  Immunological Reviews, 1989
• Involvement of specific Lyt‐2⁺ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis
  European Journal of Immunology, 1987